Wells Fargo’s Stoke Therapeutics STOK Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$261K Buy
23,005
+5,325
+30% +$60.4K ﹤0.01% 4226
2025
Q1
$118K Buy
17,680
+894
+5% +$5.95K ﹤0.01% 4577
2024
Q4
$185K Buy
16,786
+5,682
+51% +$62.7K ﹤0.01% 4357
2024
Q3
$136K Sell
11,104
-283
-2% -$3.48K ﹤0.01% 4438
2024
Q2
$154K Buy
11,387
+1,535
+16% +$20.7K ﹤0.01% 4325
2024
Q1
$133K Buy
9,852
+1,352
+16% +$18.3K ﹤0.01% 4357
2023
Q4
$44.7K Buy
8,500
+1,682
+25% +$8.85K ﹤0.01% 4896
2023
Q3
$26.9K Sell
6,818
-3,689
-35% -$14.5K ﹤0.01% 5114
2023
Q2
$112K Buy
10,507
+6,516
+163% +$69.3K ﹤0.01% 4706
2023
Q1
$33.2K Buy
3,991
+3,891
+3,891% +$32.4K ﹤0.01% 5087
2022
Q4
$923 Sell
100
-244
-71% -$2.25K ﹤0.01% 5882
2022
Q3
$5K Sell
344
-231
-40% -$3.36K ﹤0.01% 5599
2022
Q2
$8K Sell
575
-980
-63% -$13.6K ﹤0.01% 5556
2022
Q1
$33K Sell
1,555
-6,486
-81% -$138K ﹤0.01% 5491
2021
Q4
$193K Sell
8,041
-3,034
-27% -$72.8K ﹤0.01% 4920
2021
Q3
$282K Buy
11,075
+6,046
+120% +$154K ﹤0.01% 4680
2021
Q2
$169K Sell
5,029
-6,387
-56% -$215K ﹤0.01% 4797
2021
Q1
$444K Buy
11,416
+3,386
+42% +$132K ﹤0.01% 4447
2020
Q4
$497K Buy
8,030
+2,330
+41% +$144K ﹤0.01% 4440
2020
Q3
$191K Sell
5,700
-4,571
-45% -$153K ﹤0.01% 4813
2020
Q2
$245K Sell
10,271
-10,939
-52% -$261K ﹤0.01% 4640
2020
Q1
$486K Buy
21,210
+3,180
+18% +$72.9K ﹤0.01% 3935
2019
Q4
$510K Buy
18,030
+14,589
+424% +$413K ﹤0.01% 4249
2019
Q3
$74K Buy
+3,441
New +$74K ﹤0.01% 5182